Lineage Cell Therapeutics, Inc. financial data

Symbol
LCTX on NYSE
Location
Carlsbad, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 396% % 60%
Debt-to-equity 80% % 50%
Return On Equity -122% % -300%
Return On Assets -67% % -239%
Operating Margin -325% % -25%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 230,327,537 shares 22%
Common Stock, Shares, Outstanding 230,327,537 shares 22%
Entity Public Float $146,300,000 USD -21%
Common Stock, Value, Issued $494,175,000 USD 5.3%
Weighted Average Number of Shares Outstanding, Basic 228,853,000 shares 21%
Weighted Average Number of Shares Outstanding, Diluted 228,853,000 shares 21%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $10,816,000 USD 24%
Revenue from Contract with Customer, Excluding Assessed Tax $10,816,000 USD 24%
Cost of Revenue $272,000 USD -58%
Research and Development Expense $12,914,000 USD -0.32%
General and Administrative Expense $18,009,000 USD -0.27%
Costs and Expenses $45,997,000 USD 46%
Operating Income (Loss) $35,181,000 USD -55%
Nonoperating Income (Expense) $32,328,000 USD -1304%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $18,582,000 USD 20%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $67,657,000 USD -236%
Earnings Per Share, Basic 0 USD/shares -133%
Earnings Per Share, Diluted 0 USD/shares -133%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $40,463,000 USD 46%
Marketable Securities, Current $23,000 USD -100%
Accounts Receivable, after Allowance for Credit Loss, Current $127,000 USD -69%
Assets, Current $42,260,000 USD 23%
Property, Plant and Equipment, Net $2,157,000 USD 7.2%
Operating Lease, Right-of-Use Asset $2,311,000 USD -2.2%
Intangible Assets, Net (Excluding Goodwill) $31,700,000 USD -32%
Goodwill $10,672,000 USD 0%
Assets $89,639,000 USD -7.2%
Accounts Payable, Current $1,520,000 USD -4.9%
Employee-related Liabilities, Current $2,544,000 USD 2%
Accrued Liabilities, Current $486,000 USD 27%
Contract with Customer, Liability, Current $10,100,000 USD -72%
Liabilities, Current $9,382,000 USD -32%
Deferred Income Tax Liabilities, Net $273,000 USD 0%
Operating Lease, Liability, Noncurrent $1,515,000 USD -1.2%
Liabilities $68,843,000 USD 116%
Accumulated Other Comprehensive Income (Loss), Net of Tax $4,286,000 USD -48%
Retained Earnings (Accumulated Deficit) $467,849,000 USD -17%
Stockholders' Equity Attributable to Parent $22,040,000 USD -67%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $20,796,000 USD -68%
Liabilities and Equity $89,639,000 USD -7.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $4,886,000 USD 16%
Net Cash Provided by (Used in) Financing Activities $5,044,000 USD -64%
Net Cash Provided by (Used in) Investing Activities $1,903,000 USD
Common Stock, Shares Authorized 450,000,000 shares 0%
Common Stock, Shares, Issued 230,327,537 shares 22%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $1,988,000 USD -76%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $40,977,000 USD 45%
Interest Paid, Excluding Capitalized Interest, Operating Activities $14,000 USD 600%
Deferred Tax Assets, Valuation Allowance $86,314,000 USD 7.2%
Deferred Tax Assets, Gross $93,428,000 USD 9.6%
Operating Lease, Liability $2,538,000 USD -3%
Payments to Acquire Property, Plant, and Equipment $97,000 USD 155%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $69,053,000 USD -230%
Operating Lease, Liability, Current $1,023,000 USD -5.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Deferred Income Tax Expense (Benefit) $0 USD
Deferred Tax Assets, Operating Loss Carryforwards $68,180,000 USD 7.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 2,000,000 shares 0%
Unrecognized Tax Benefits $3,153,000 USD 6.4%
Operating Lease, Payments $305,000 USD 0.99%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $0 USD -100%
Deferred Tax Assets, Net of Valuation Allowance $7,114,000 USD 51%
Share-based Payment Arrangement, Expense $4,969,000 USD 3%